Bristol-Myers Squibb Earnings: Currency Headwinds Take The Shine Off Encouraging New Drug Sales

The revenue decline was amplified to the tune of $184 million by the negative impact of a stronger U.S. dollar. Bristol-Myers Squibb expects currency headwinds to continue this year and has guided its full-year worldwide sales for 2015 to be between $14.4 and $15.0 billion. On a constant currency basis, the company is showing momentum, however, an its pipeline across several disease areas is improving. The increasing adoption of blood thinner medicine Eliquis, continue growth in its immuno-oncol...